Review of ubenimex (Bestatin): clinical research
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 45 (2-3) , 55-60
- https://doi.org/10.1016/0753-3322(91)90123-b
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adultsBiomedicine & Pharmacotherapy, 1990
- Biological activity of the main metabolites of ubenimex in humans.The Journal of Antibiotics, 1988
- Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladderCancer Immunology, Immunotherapy, 1987
- The role of immunotherapy in acute myelogenous leukemiaArchives of internal medicine (1960), 1983
- Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cellsInternational Journal of Immunopharmacology, 1982
- Effect of bestatin on mouse immune system and experimental murine tumors.The Journal of Antibiotics, 1980
- Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.The Journal of Antibiotics, 1976